COVID-19 promotes life-saving policy change for opioid addiction

Facing the US pandemic COVID-19. USA, The US Administration of Mental Health and Substance Abuse Services. USA (SAMHSA) has announced new policy changes regarding home treatment of opioid use disorder (OUD). Last week, the agency issued a directive to allow some patients in opioid treatment (OTP) programs to take their medications home, announcing that states may request "general exceptions" for all stable patients in an OTP to receive a 28-day supply of home-dose medications such as methadone and buprenorphine, for the treatment of opioid use disorder (OUD). The agency also said states can now request up to 14 days of take-home medications for patients who are less stable but who, in OTP doctors' opinion, can safely handle this level of take-home medications. "SAMHSA recognizes the evolving problems surrounding COVID-19 and the emerging needs that OTPs continue to face," the agency writes.

> Read the article

Source: NewsDio is a website intended to deliver news related to Business, Tech, Finance, and Sports networks, March 21, 2020
Source: Substance Abuse and Mental Health Services Administration https://www.samhsa.gov/coronavirus



©2020 Ventura County Behavioral Health • Hanstad Consulting • Website: Idea Engineering